In this the second part of this conversation with Stephen, Emily got the chance to ask him about the work he does around naloxone advocacy. (Note: this film was recorded while Stephen was in a previous post with the Scottish Drugs Forum).
Author: Nigel Brunsdon
Harm Reduction International has compiled the first global data snapshot on injecting drug use and related HIV and other harms among children and young people under the age of 18.
Young people who inject drugs have specific developmental, social and environmental vulnerabilities. They are less likely to use harm reduction and treatment services and are less informed about risks and their rights. Early onset of injecting, and being a new injector, have been associated with increased risks of HIV and hepatitis C transmission, while specific groups of young people, especially those that are street involved, are at considerably higher risk.
This handbook has been designed to be a practical tool for activists to support them to assess their local circumstances, identify priorities for advocacy and to design, deliver and review their own TB advocacy campaigns. Each setting and context will throw up different issues and challenges for TB advocacy.
TB is a growing threat to people who use drugs, particularly when set against the backdrop of high vulnerability to, and prevalence of, HIV. As such it is important for drug user advocates from drug user organisations and PLHIV groups to help develop a coordinated advocacy response.
Emily Winkelstein talks about the need for people in the drugs field to support each other emotionally as we are all carrying a burden of grief and trauma.
Greg Scott talking about family engagement around naloxone, and the power this has. Including why it’s important for all of us to have easy access to naloxone for all family members even if we don’t expect to have a use for it.
Hadiyah Charles the Hepatitis C Advocacy Manager from the Harm Reduction Coalition talks about the need for greater HepC testing.
This presentation was delivered to the National Needle Exchange Forum meeting in Bournemouth. I was talking about the Harm Reduction Cafe community project that I’ve developed as part of my job with HIT.
Update: The Harm Reduction Cafe website is now closed, it may be back but that depends on how much spare time I can find.
Sharon Stancliff MD talking about the development around the latest Opioid Overdose Prevention Toolkit from SAMHSA, and the way it promotes naloxone distribution.
Update: As of 2018 the toolkit has now been revised and updated.
Sharon Stancliff talks about the issues delaying wider distribution of naloxone around the USA, including issues like legality and costs.
Sharon Stancliff talks about the problems caused by the way the USA influences the rest of the world. Especially in terms of it’s impact on harm reduction and international drug policies.